Pharmacovigilance: Knowledge, Attitude and Practice among Medical Professionals at a Tertiary Care Hospital in Nepal
Keywords:
Adverse drug reactions, Attitude, Knowledge, Medical Professionals, Pharmacovigilance, PracticeAbstract
Introduction: Awareness regarding pharmacovigilance and adverse drug reaction reporting by medical professionals significantly contribute to the safer use of medicine. Therefore, the objective of this study was to assess the knowledge, attitude, and practices regarding pharmacovigilance among the medical professionals at a tertiary care hospital in Nepal.
Methods: This study was a descriptive cross-sectional study conducted at Lumbini Medical College and Teaching Hospital. Printed questionnaires were distributed to all the medical professionals and collected data were analyzed to find the knowledge, attitude, and practices of the medical professionals regarding pharmacovigilance.
Results: A total of 107 medical professionals, 77 (71.96%) males and 30 (28.04%) females, participated in the study. The overall response rate was 98.16%. In this study,70.1% of medical professionals knew the definition of pharmacovigilance, and more than half of the participants(63.6%) did not know the existence of the national pharmacovigilance center. Regarding attitude, 52.3% of the medical professionals strongly agreed that adverse drug reaction reporting and monitoring systems were beneficial to patients or improved patient care. Half of the medical professionals would sometimes counsel the patients about adverse drug reactions. Almost half of medical professionals mentioned that the major factor behind underreporting was insufficient knowledge of where to report adverse drug reactions. Training on pharmacovigilance was the main recommendation from the participants (52.3%) to improve the pharmacovigilance program.
Conclusion: There is room for improvement in the knowledge, attitude and practice of the participants. Most medical professionals suggested training or continuing medical education as a way to improve pharmacovigilance programs.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2021 Kamal Kandal, Naresh Karki, Kyushu Shah, Pravin Prasad
This work is licensed under a Creative Commons Attribution 4.0 International License.
The Journal of Lumbini Medical College (JLMC) publishes open access articles under the terms of the Creative Commons Attribution(CC BY) License which permits use, distribution and reproduction in any medium, provided the original work is properly cited.JLMC requires an exclusive licence allowing to publish the article in print and online.
The corresponding author should read and agree to the following statement before submission of the manuscript for publication,
License agreement
In submitting an article to Journal of Lumbini Medical College (JLMC) I certify that:
- I am authorized by my co-authors to enter into these arrangements.
- I warrant, on behalf of myself and my co-authors, that:
- the article is original, has not been formally published in any other peer-reviewed journal, is not under consideration by any other journal and does not infringe any existing copyright or any other third party rights;
- I am/we are the sole author(s) of the article and have full authority to enter into this agreement and in granting rights to JLMC are not in breach of any other obligation;
- the article contains nothing that is unlawful, libellous, or which would, if published, constitute a breach of contract or of confidence or of commitment given to secrecy;
- I/we have taken due care to ensure the integrity of the article. To my/our - and currently accepted scientific - knowledge all statements contained in it purporting to be facts are true and any formula or instruction contained in the article will not, if followed accurately, cause any injury, illness or damage to the user.
- I, and all co-authors, agree that the article, if editorially accepted for publication, shall be licensed under the Creative Commons Attribution License 4.0. If the law requires that the article be published in the public domain, I/we will notify JLMC at the time of submission, and in such cases the article shall be released under the Creative Commons 1.0 Public Domain Dedication waiver. For the avoidance of doubt it is stated that sections 1 and 2 of this license agreement shall apply and prevail regardless of whether the article is published under Creative Commons Attribution License 4.0 or the Creative Commons 1.0 Public Domain Dedication waiver.
- I, and all co-authors, agree that, if the article is editorially accepted for publication in JLMC, data included in the article shall be made available under the Creative Commons 1.0 Public Domain Dedication waiver, unless otherwise stated. For the avoidance of doubt it is stated that sections 1, 2, and 3 of this license agreement shall apply and prevail.
Please visit Creative Commons web page for details of the terms.
